The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study.

Autor: Chacko, Jithin1 (AUTHOR), Dhandapani, Shankar2 (AUTHOR), Jahagiridhar, Vidhya2 (AUTHOR), Swaminathan, Krishnan3 (AUTHOR)
Zdroj: Indian Journal of Pharmacology. May/Jun2021, Vol. 53 Issue 3, p229-233. 5p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje